Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | Shannon James Samuel | Mar 26, 2026 | Buy | $43.95K | 5,000 |
| 10% Owner | GILEAD SCIENCES, INC. | Feb 13, 2026 | Buy | $2M | 3,739,000 |
| CFO | Frankenfield Christopher James | Jan 2, 2026 | Sell | $4.52K | 7,030 |
| SVP, FINANCE AND ACCOUNTING | Brennan Kevin M. | Jan 2, 2026 | Sell | $1.17K | 1,826 |
| Director | Shannon James Samuel | Jun 17, 2025 | Buy | $17.22K | 25,000 |
| CEO | Russo Rene | Jun 16, 2025 | Buy | $24.68K | 36,289 |
| Director | Shannon James Samuel | Jun 16, 2025 | Buy | $30.87K | 45,000 |
| 10% Owner | GILEAD SCIENCES, INC. | Jun 5, 2025 | Buy | - | 13,335,000 |
| 10% Owner | GILEAD SCIENCES, INC. | Jun 5, 2025 | Buy | - | 13,335,000 |
| 10% Owner | GILEAD SCIENCES, INC. | Jun 5, 2025 | Buy | - | 13,335,000 |
| 10% Owner | GILEAD SCIENCES, INC. | Jun 5, 2025 | Buy | - | 13,335,000 |
| SVP, FINANCE AND ACCOUNTING | Brennan Kevin M. | Jan 2, 2025 | Sell | $1.77K | 1,803 |
| CFO | Frankenfield Christopher James | Jan 2, 2025 | Sell | $6.84K | 6,954 |
| 10% Owner | GILEAD SCIENCES, INC. | Dec 18, 2024 | Buy | $1.83M | 1,759,978 |
| 10% Owner | GILEAD SCIENCES, INC. | Dec 18, 2024 | Buy | $6.34M | 6,092,816 |
| 10% Owner | GILEAD SCIENCES, INC. | Apr 2, 2024 | Buy | $368.79K | 485,250 |
| 10% Owner | GILEAD SCIENCES, INC. | Apr 2, 2024 | Buy | $2.95M | 3,882,450 |
| 10% Owner | Atlas Venture Fund XI, L.P. | Feb 8, 2024 | Sell | $469.12 | 733 |
| 10% Owner | Atlas Venture Fund XI, L.P. | Feb 8, 2024 | Sell | $170.88 | 267 |
| 10% Owner | Atlas Venture Fund XI, L.P. | Jan 12, 2024 | Sell | $1.28K | 1,540 |
| 10% Owner | Atlas Venture Fund XI, L.P. | Jan 12, 2024 | Sell | $464.8 | 560 |
| 10% Owner | Atlas Venture Fund XI, L.P. | Jan 11, 2024 | Sell | $1.36K | 1,566 |
| 10% Owner | Atlas Venture Fund XI, L.P. | Jan 11, 2024 | Sell | $495.03 | 569 |
| 10% Owner | Bain Capital Life Sciences Investors, LLC | Dec 10, 2021 | Buy | $208.56K | 21,812 |
| 10% Owner | Bain Capital Life Sciences Investors, LLC | Dec 10, 2021 | Buy | $32.64K | 3,188 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.